Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer

Huang Y, Dai S, Yin W, Luo F, Li Y

OncoTargets and Therapy 2023, 16:1015-1020

Published Date: 29 November 2023